| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BAXTER INTERNATIONAL INC | Director | Common Stock, $1 par value | 27.9K | $1.19M | $42.50 | May 7, 2024 | Direct |
| Paragon 28, Inc. | Director | Common Stock | 40.2K | $367K | $9.12 | May 17, 2024 | Direct |
| Sigilon Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | $0.75 | Aug 11, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| FNA | Paragon 28, Inc. | May 17, 2024 | 1 | $0 | 4 | May 21, 2024 | Director |
| BAX | BAXTER INTERNATIONAL INC | May 7, 2024 | 1 | $0 | 4 | May 9, 2024 | Director |
| SGTX | Sigilon Therapeutics, Inc. | Aug 11, 2023 | 3 | -$40K | 4 | Aug 11, 2023 | Director |
| SGTX | Sigilon Therapeutics, Inc. | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
| FNA | Paragon 28, Inc. | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
| BAX | BAXTER INTERNATIONAL INC | May 2, 2023 | 1 | $0 | 4 | May 4, 2023 | Director |
| SGTX | Sigilon Therapeutics, Inc. | May 26, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
| FNA | Paragon 28, Inc. | May 18, 2022 | 1 | $0 | 4 | Feb 22, 2023 | Director |
| BAX | BAXTER INTERNATIONAL INC | May 3, 2022 | 1 | $0 | 4 | May 5, 2022 | Director |
| FNA | Paragon 28, Inc. | Oct 14, 2021 | 1 | $0 | 4 | Dec 3, 2021 | Director |
| FNA | Paragon 28, Inc. | Oct 14, 2021 | 0 | $0 | 3 | Oct 14, 2021 | Director |
| MAAC | Montes Archimedes Acquisition Corp | Sep 30, 2021 | 0 | $0 | 4 | Oct 4, 2021 | Director |
| SGTX | Sigilon Therapeutics, Inc. | Jun 24, 2021 | 1 | $88.6K | 4 | Jun 28, 2021 | Director |